2 |
Basal insulin and cardiovascular and other outcomes in dysglycemia.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
|
|
BASE
|
|
Show details
|
|
3 |
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
|
|
BASE
|
|
Show details
|
|
4 |
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
|
|
BASE
|
|
Show details
|
|
|
|